Brian Henick, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Brodalumab in the Treatment of Immune-Related Adverse Events (NCT06673329) | Brian Henick, MD | 2025-03-11 |
| Liver Directed RT + Chemo-immunotherapy for ES-SCLC (NCT04923776) | Brian Henick, MD | 2021-09-20 |
Track Brian Henick, MD automatically
Every clearance here is in the API, with alerts when new ones post.